GIULIANA SANTORO: Open Payments
NPI 1619450681 · NORTH MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 64 payments from 26 companies in 2025. Trend: 2023 $875 · 2024 $1,126 · 2025 $1,427
Food & beverage: $1,328Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $489 |
| TerSera Therapeutics LLC | 4 | $109 |
| AstraZeneca Pharmaceuticals LP | 1 | $105 |
| Daiichi Sankyo Inc. | 3 | $69 |
| BeOne Medicines USA, Inc. | 3 | $59 |
| ABBVIE INC. | 2 | $59 |
| Immunocore Limited | 2 | $51 |
| Astellas Pharma US Inc | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Incyte Corporation | 2 | $37 |
Products named: RYBREVANT, Zoladex, CARVYKTI, KIMMTRAK, TALVEY, TEVIMBRA, Enhertu, Vyloy.
Industry payments across FL — which companies pay providers there.
